- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04692818
3D Ultrasound Breast Imaging
January 5, 2024 updated by: Shigao Chen, Mayo Clinic
3D Multimodal Ultrasound Imaging for Breast Cancer
The purpose of this research is to study the efficacy of a new ultrasound imaging method for diagnosis of breast mass.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
125
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic in Rochester
-
Contact:
- Bobbie Ott
- Phone Number: 507-293-0922
- Email: ott.bobbie@mayo.edu
-
Principal Investigator:
- Shigao Chen, Ph.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adult women, ≥ 18 years of age.
- Breast lesion and are scheduled for clinically-indicated biopsy.
Exclusion Criteria:
- < 18 years of age.
- Previous breast surgery or breast implant.
- Lacking capacity to consent.
- Pregnant or lactating.
- Receiving cancer therapy such as chemotherapy or radiation therapy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Clinically indicated breast tumor biopsy
Subjects with breast lesion and are scheduled for clinically-indicated biopsy will have 3D Multimodal Ultrasound Imaging performed
|
2D B-mode, Doppler, and shear wave elastography images of the lesion
3D B-mode imaging, microvessel imaging, and shear wave elastography
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BI-RADS Score
Time Frame: Baseline
|
BI-RADS scores will be obtained using 2D B-mode ultrasound images from the GE Logiq E10 clinical scanner, and using 3D B-mode images from the Verasonics scanner.
A 7-point BI-RADS scale will be used, with a score of 1, 2, or 3 considered negative and 4a, 4b, 4c, and 5 considered positive.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Shigao Chen, Ph.D., Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 19, 2021
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
December 30, 2020
First Submitted That Met QC Criteria
December 30, 2020
First Posted (Actual)
January 5, 2021
Study Record Updates
Last Update Posted (Estimated)
January 8, 2024
Last Update Submitted That Met QC Criteria
January 5, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-010751
- W81XWH-21-1-0063 (Other Grant/Funding Number: Department of Defense)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Tumor
-
National University Hospital, SingaporeUnknownBreast Tumor TissueSingapore
-
University of Alabama at BirminghamBracco CorporateActive, not recruitingBreast Malignant Tumor | Breast Benign TumorUnited States
-
KK Women's and Children's HospitalRecruiting
-
Relay Therapeutics, Inc.Active, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Unresectable Solid Tumor | PIK3CA MutationUnited States
-
Pontificia Universidad Catolica de ChileComisión Nacional de Investigación Científica y TecnológicaRecruitingBreast Cancer | Breast Tumor | Mammary Cancer | Mammary TumorChile
-
University Hospital, ToursInstitut Cancerologie de l'OuestTerminatedMetastatic Breast Cancer | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive Tumor | HER-2 Negative TumorFrance
-
Nuvation Bio Inc.WithdrawnBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of Breast | Breast Tumor | Cancer of the BreastUnited States
-
Relay Therapeutics, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Unresectable Solid Tumor | PIK3CA MutationUnited States, Spain, France, Italy
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Not yet recruitingBreast Cancer | Neoplasm, Breast | Malignant Neoplasm of Breast | Breast Tumor | Mammary Cancer | Mammary Neoplasms, Human | Tumor, Breast | Mammary NeoplasmUnited States
-
National Taiwan University HospitalRecruitingTumor, Brain | Tumor Skin | Tumor, BreastTaiwan
Clinical Trials on GE Logiq E10 clinical ultrasound scanner
-
Mayo ClinicActive, not recruitingBreast CancerUnited States
-
Seoul National University HospitalCompleted
-
University of WashingtonGeneral ElectricCompletedArterial Occlusive Diseases | Hypertension | Pregnancy | Pregnancy, High Risk | Evidence of Liver TransplantationUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Cancer Institute (NCI); University of California, San Diego; GE Healthcare and other collaboratorsCompletedHepatocellular Carcinoma | Chemoembolization, TherapeuticUnited States
-
University of MichiganTerminatedTendon Injuries | Bone Injuries | Muscle InjuriesUnited States
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingLiver Diseases | CirrhosisChina
-
Vilnius UniversityCompletedNeonatal Infection | Pre-TermLithuania
-
Helse Nord-Trøndelag HFNorwegian University of Science and Technology; St. Olavs HospitalCompletedStroke | Transient Ischemic Attack | Ischemic Attack, Transient | Cerebrovascular Accident | Cerebrovascular ApoplexyNorway
-
Clinical Nutrition Research Centre, SingaporeCompletedObesity | Diabetes | Impaired Glucose ToleranceSingapore